Second Quarter Financial Results 2024/25
Reading Time: 6 minutes Hong Kong: Lenovo GroupLimited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries (‘the Group’), today announced Q2 results for fiscal year 2024/25, reporting significant increases and growth in net income, year-on-year revenue growth for the 4th consecutive quarter, and strong double-digit
Desert Control Releases Q3 2024 Report and Year-to-Date Company Update
Reading Time: 4 minutes Sandnes, Norway, 15 November 2024 — Desert Control AS (DSRT) announces its third-quarter report and interim financial results for the fiscal period ending 30 September 2024. Desert Control continued its positive momentum in the third quarter of 2024, achieving milestones in market
Experian Named to World’s Best Workplaces™ 2024 by Fortune and Great Place to Work®
Reading Time: 3 minutes Dublin, Ireland: Experian today announced it was named one of the World’s Best Workplaces™ 2024 by Fortune and Great Place to Work®, which recognises a select 25 global companies that are building the best workplace cultures in the world. The honour
Ingredion and Lantmännen form strategic partnership to accelerate the development of plant-based proteins
Reading Time: 2 minutes Agreement expands both companies’ capabilities in servicing a fast-growing and evolving alternative protein market. Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, and Lantmännen announce a new long-term collaboration. Lantmännen is
Rescheduling of the Q3 2024 Interim Report – New Publication Date: November 14, 2024
Reading Time: < 1 minute Stockholm – 2024-11-14 The management of Evolear AB (publ) has decided to bring forward the release of the Q3 interim report for July-September 2024. The report will now be published on Thursday, November 14, 2024, after market closing instead of
CHMP issues positive recommendation for approval of lecanemab in the EU
Reading Time: 5 minutes Stockholm, November 14, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic’s partner Eisai’s marketing authorization application (MAA) for lecanemab as treatment of
Africa Energy Announces Third Quarter 2024 Results
Reading Time: 7 minutes VANCOUVER, BC, Nov. 14, 2024 /CNW/ – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas exploration company, announces corporate update and financial and operating results for the three and nine
Volvo Group Capital Markets Day – Gearing up for growth
Reading Time: 2 minutes Today, November 14, 2024, the Volvo Group held its Capital Markets Day at the Volvo Trucks Customer Center in New River Valley, Virginia, USA. At the event, President and CEO Martin Lundstedt together with Group Management presented the strategic direction to
Noble Corporation plc announces submission of request for removal from trading and official listing on Nasdaq Copenhagen
Reading Time: 6 minutes SUGAR LAND, TEXAS, Nov. 14, 2024 /PRNewswire/ – Noble Corporation plc (“Noble“, the “Company“) (NYSE: NE, CSE: NOBLE) announces that today, Noble has submitted a request for the voluntary removal of its shares (in the form of share entitlements) (the “Danish
ExpreS2ion announces TO 10 warrant exercise price and start of exercise period
Reading Time: 9 minutes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, RUSSIA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE,